IL33 and Alzheimer disease: A recent study showed that topical application of propionate, a microbial metabolite abundant on healthy skin but reduced in AD skin, diminished inflammation in a MC903-induced AD mouse model by inhibiting IL-33 production in keratinocytes (26).